The lab will contain 48 workbenches with services that include mass spectrometry and ligand binding assays, flow cytometry, biomarkers, and cell culture.
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
To use Insilico's machine learning technology and Pandomics Discovery Platform to identify real-world evidence for potential targets in a variety of diseases
New streams of real-world data from electronic health records and other data sources, with advances in ML, will be crucial for creating next-gen clinical trials
Jennifer Bradford, Ph.D., Head of Data Science at PHASTAR08.19.19